CD8A and lung cancer: A meta-analysis demonstrated that the presence of CD8+ cytotoxic T cells, CD20+ B cells, natural killer (NK) cells, and FOXP3+ Tregs is significantly associated with improved survival in early-stage lung cancer [21].